Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry-Reference-Cited by-同舟云学术

Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry

Published:2017-06-23 Issue:1 Volume:36 Page:189-195
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Biasoli Irene¹^ORCID,Castro Nelson²,Delamain Marcia³,Silveira Talita⁴,Farley James⁵,Simões Belinda Pinto⁶,Solza Cristiana⁷,Praxedes Monica⁸,Baiocchi Otávio⁹,Gaiolla Rafael¹⁰,Franceschi Fernanda¹¹,Sola Caroline Bonamin¹²,Boquimpani Carla¹³,Clementino Nelma¹⁴,Perini Guilherme¹⁵,Pagnano Kátia³,Steffenello Giovanna¹⁶,Tabacof Jacques¹⁷,de Freitas Colli Gilberto²,Soares Andrea⁷,de Souza Carmino³,Chiattone Carlos Sérgio⁴,Milito Cristiane¹,Morais José Carlos¹,Spector Nelson¹

Affiliation:

1. School of Medicine; Universidade Federal do Rio de Janeiro; Rio de Janeiro Brazil

2. Hospital de Cancer de Barretos; Barretos Brazil

3. Hematology and Hemotherapy Center; University of Campinas; Campinas Brazil

4. São Paulo Santa Casa Medical School; São Paulo Brazil

5. Liga Norte Rio Grandense Contra o Cancer; Natal Brazil

6. USP-Ribeirão Preto; São Paulo Brazil

7. Universidade do Estado do Rio de Janeiro; Rio de Janeiro Brazil

8. Universidade Federal Fluminense; Niterói Brazil

9. UNIFESP; São Paulo Brazil

10. UNESP; São Paulo Brazil

11. Fundação Amaral Carvalho; Jaú Brazil

12. Universidade Federal do Paraná; Curitiba Brazil

13. HEMORIO; Rio de Janeiro Brazil

14. Universidade Federal de Minas Gerais; Belo Horizonte Brazil

15. Hospital Israelita Albert Einstein-SP; São Paulo Brazil

16. Universidade Federal de Santa Catarina; Florianópolis Brazil

17. ESHO-Centro Paulistano de Oncologia; São Paulo Brazil

Funder

FAPERJ (Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Takeda Farmacêutica Brasil

Novartis Biociências

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2450/fullpdf

Reference30 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management;Ansell;Am J Hematol,2016

3. Hodgkin's lymphoma mortality in the Americas, 1997-2008: achievements and persistent inadequacies;Chatenoud;Int J Cancer,2013

4. C-MOPP/ABV yields good results in a public hospital population with Hodgkin disease in Brazil;Spector;Cancer,1993

5. Hodgkin lymphoma in Africa: present and future;Stefan;Transfusion and Apheresis Science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability;Oncotarget;2023-12-12

2. Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma;Annals of Hematology;2023-10-05

3. Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry;eJHaem;2023-10-04

4. The clinical utility of PET/CT scan and tissue biopsy in the management and follow-up of paediatric Hodgkin lymphoma in South Africa;South African Journal of Surgery;2023-09

5. Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry;Annals of Hematology;2023-07-21